Helga Gardarsdottir, PhD, FISPE

Associate Professor
University of Utrecht
Utrecht, Netherlands

Dr. Helga Gardarsdottir is associate professor at the Division of Pharmacoepidemiology & Clinical Pharmacology. Her primary research interests include the application and development of tools and approaches to evaluate the consequences of regulatory and clinical decision making and to improve robustness of pharmacoepidemiological safety studies used in benefit-risk evaluations. Within this scope her special focus is on bio-based therapies.
Dr. Gardarsdottir was trained as a pharmacist and a pharmacoepidemiologist. She is winner of a personal VENI prize from the Netherlands Organisation for Scientific Research (NWO) and has led and participated in a number of international multi-country research projects including the IMI-PROTECT project. She is the co-lead for the Real-World Evidence task force of the International Society of Pharmacoepidemiology and associate editor of the journal 'Pharmacoepidemiology & Drug Safety'.

I do not have any relevant financial / non-financial relationships with any proprietary interests.

Presentation(s):

• It Takes a Village: Strategic Global Collaborations to Advance RWE Within ISPE

  Friday, August 26, 2022
  3:30 PM – 5:00 PM CEST

• Discontinuation of Infliximab Treatment in IBD Patients: A Comparison Between Patients Who Retransitioned to Originator and Those Who Remained on Biosimilar

  Saturday, August 27, 2022
  1:45 PM – 1:50 PM CEST

• Real-World Evidence Studies in the post-COVID-19 Era: Methodological Considerations for Pandemic Related Disruptions

  Saturday, August 27, 2022
  4:15 PM – 5:45 PM CEST